Sale of 5,530 shares at $204.1357 per share.
Reporting Person Mancini Anthony · Officer Title See Remarks · Transaction Code S
Traded Sep 10, 2026 · Disclosed Sep 14, 2026
Source: SEC Form 4 · 0002124509-26-000004 · filed 2026-09-14 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Revolution Medicines, Inc. (RVMD)." Disclosed 2026-09-14. https://desqlong.com/cards/0002124509-26-000004-3 (retrieved 2026-09-26).